CYCLOSPORINE A-INDUCED CHOLESTASIS IN THE RAT - BENEFICIAL-EFFECTS OF S-ADENOSYL-L-METHIONINE

被引：8

作者：

FERNANDEZ, E ^{[1
]}

MUNOZ, ME ^{[1
]}

ROMAN, ID ^{[1
]}

GALAN, AI ^{[1
]}

GONZALEZBUITRAGO, JM ^{[1
]}

JIMENEZ, R ^{[1
]}

机构：

[1] UNIV SALAMANCA,FAC PHARM,DEPT PHYSIOL & PHARMACOL,APTDO 449,E-37080 SALAMANCA,SPAIN

来源：

DRUG INVESTIGATION | 1992年 / 4卷

关键词：

D O I：

10.1007/BF03258364

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Cyclosporin A, a powerful immunosuppressor drug, induces nephrotoxicity and hepatotoxicity. The purpose of this study was to evaluate the ability of S-adenosyl-L-methionine (SAMe) to antagonise the cyclosPorin A-induced hepatotoxicity in rats treated with cyclosporin, A plus SAMe. Cyclosporin A treatment for 1 or 2 weeks increases plasma bilirubin, alters some plasma biochemical indicators of hepatic and renal function, causes cholestasis and reduces the biliary concentration and secretion of bile acid and other bile components. SAMe pretreatment and simultaneous treatment with SAMe plus cyclosporin A suppresses bilirubin increases in plasma, attenuates cholestasis and totally antagonises the adverse effects of cyclosporin A on bile acid secretion. Although cyclosporin A-induced hepatotoxicity in the rat is a multifactorial phenomenon, we suggest that the hepatoprotective effects of SAMe against cyclosporin A could be related to its regulatory function of membrane lipid composition and fluidity, either alone or combined with stimulation of the hepatic synthesis of thiol compounds.

引用

页码：54 / 63

页数：10

共 44 条

[11]

Di Padova C., Di Padova F., Tritapepe R., Stramentinoli G., S-Adenosyl-L-methionine protection against alfa-naphthyl-iso-thiocyanate-induced cholestasis in the rat, Toxicology Letters, 29, pp. 131-136, (1985)

[12]

Duruibe V.A., Okonmah A., Blyden G.T., Effect of ciclosporin on rat liver and kidney glutathione content, Pharmacology, 39, pp. 205-212, (1989)

[13]

Farthing J.G., Clark M.L., Nature of the toxicity of cyclosporin A in the rat, Biochemical Pharmacology, 30, pp. 3311-3316, (1981)

[14]

Friedel H.A., Goa K.L., Benfield P., S-Adenosyl-L-methionine: a review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism, Drugs, 38, pp. 389-416, (1989)

[15]

Galan A., Roman D., Cava F., Munoz M.E., Gonzalez J., Esteller A., Jimenez R., Cyclosporin A and hepatobiliary transport mechanisms. Abstract, Journal of Hepatology, 11, 2, (1990)

[16]

Galan A.I., Zapata A.J., Roman I.D., Munoz M.E., Muriel C., Et al., Impairment of maximal bilirubin secretion by cyclosporin A in the rat, Archives Internationales de Physiologic de Biochimie et de Biophysique, 99, pp. 373-376, (1991)

[17]

Hardison W.G.M., Wood G.A., Importance of bicarbonate in bile salt independent fraction of bile flow, American Journal of Physiology, 235, (1978)

[18]

Inselmann G., Hannemann J., Baumann K., Cyclosporine A induced lipid peroxidation and influence on glucose-6-phospha-tase in rat hepatic and renal microsomes, Research Communications in Chemical Pathology and Pharmacology, 68, pp. 189-203, (1990)

[19]

Jimenez R., Munoz M.E., Fernandez E., Roman I.D., Galan A.I., Evaluation and mechanisms of the lithogenic effects of cyclosporine A (CyA). Abstract, Journal of Hepatology, 13, 2, (1991)

[20]

Kahan B.B., Cyclosporine, New England Journal of Medicine, 321, pp. 1725-1738, (1989)

← 1 2 3 4 5 →